Monoclonal Mouse anti‑Human NKIRAS2 Antibody (clone 2G9, IHC, WB) LS‑C133732
Monoclonal Mouse anti‑Human NKIRAS2 Antibody (clone 2G9, IHC, WB) LS‑C133732
Antibody:
NKIRAS2 Mouse anti-Human Monoclonal (2G9) Antibody
Application:
IHC, IHC-P, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
NKIRAS2 Mouse anti-Human Monoclonal (2G9) Antibody
Application:
IHC, IHC-P, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
NKIRAS2 antibody LS-C133732 is an unconjugated mouse monoclonal antibody to human NKIRAS2. Validated for ELISA, IHC and WB.
Target
Human NKIRAS2
Synonyms
NKIRAS2 | DKFZP434N1526 | KappaB-Ras2 | KBRAS2 | Kappa B-Ras protein 2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1,k
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites by Protein A
Immunogen
NKIRAS2 (AAH07450, 1 aa ~ 192 aa) full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Specificity
Human NKIRAS2
Applications
- IHC
- IHC - Paraffin (3 µg/ml)
- Western blot
- ELISA
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Immunohistochemistry: Formalin-fixed paraffin-embedded sections. Sandwich ELISA: Recombinant protein. Western Blot: Cell lysate, Recombinant protein.
Storage
Store at -20°C or lower. Aliquot to avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Immunofluorescence, Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
IHC, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/18/2024